Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Status of essential trace minerals and oxidative stress in viral hepatitis C patients with nonalcoholic fatty liver disease.

Guo CH, Chen PC, Ko WS.

Int J Med Sci. 2013 Apr 17;10(6):730-7. doi: 10.7150/ijms.6104. Print 2013.

2.

Role of certain trace minerals in oxidative stress, inflammation, CD4/CD8 lymphocyte ratios and lung function in asthmatic patients.

Guo CH, Liu PJ, Hsia S, Chuang CJ, Chen PC.

Ann Clin Biochem. 2011 Jul;48(Pt 4):344-51. doi: 10.1258/acb.2011.010266. Epub 2011 May 5.

PMID:
21546427
3.

Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis.

Lonardo A, Ballestri S, Adinolfi LE, Violi E, Carulli L, Lombardini S, Scaglioni F, Ricchi M, Ruggiero G, Loria P.

Can J Gastroenterol. 2009 Apr;23(4):273-8.

4.

Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD).

Madan K, Bhardwaj P, Thareja S, Gupta SD, Saraya A.

J Clin Gastroenterol. 2006 Nov-Dec;40(10):930-5.

PMID:
17063114
5.

Linkage of some trace elements, peripheral blood lymphocytes, inflammation, and oxidative stress in patients undergoing either hemodialysis or peritoneal dialysis.

Guo CH, Wang CL, Chen PC, Yang TC.

Perit Dial Int. 2011 Sep-Oct;31(5):583-91. doi: 10.3747/pdi.2009.00225. Epub 2010 Jun 30.

PMID:
20592101
6.

Patients with Nonalcoholic Fatty Liver Disease (NAFLD) have Higher Oxidative Stress in Comparison to Chronic Viral Hepatitis.

Kumar A, Sharma A, Duseja A, Das A, Dhiman RK, Chawla YK, Kohli KK, Bhansali A.

J Clin Exp Hepatol. 2013 Mar;3(1):12-8. doi: 10.1016/j.jceh.2012.10.009. Epub 2012 Nov 2.

7.

Blood trace minerals concentrations and oxidative stress in patients with obstructive sleep apnea.

Chen PC, Guo CH, Tseng CJ, Wang KC, Liu PJ.

J Nutr Health Aging. 2013;17(8):639-44. doi: 10.1007/s12603-013-0023-x.

PMID:
24097016
8.

Reduced heme oxygenase-1 expression in steatotic livers infected with hepatitis C virus.

Abdalla MY, Mathahs MM, Ahmad IM.

Eur J Intern Med. 2012 Oct;23(7):649-55. doi: 10.1016/j.ejim.2012.05.001. Epub 2012 May 27.

PMID:
22939811
9.

Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C virus infection and non-alcoholic fatty liver disease.

Vecchiet J, Falasca K, Cacciatore P, Zingariello P, Dalessandro M, Marinopiccoli M, D'Amico E, Palazzi C, Petrarca C, Conti P, Pizzigallo E, Guagnano MT.

Ann Clin Lab Sci. 2005 Autumn;35(4):415-22.

PMID:
16254258
10.

Trace metal imbalance associated with oxidative stress and inflammatory status in anti-hepatitis C virus antibody positive subjects.

Guo CH, Chen PC, Lin KP, Shih MY, Ko WS.

Environ Toxicol Pharmacol. 2012 Mar;33(2):288-96. doi: 10.1016/j.etap.2011.12.018. Epub 2011 Dec 27.

PMID:
22240188
11.

Association between insulin resistance and oxidative stress parameters in obese adolescents with non-alcoholic fatty liver disease.

Pirgon Ö, Bilgin H, Çekmez F, Kurku H, Dündar BN.

J Clin Res Pediatr Endocrinol. 2013;5(1):33-9.

12.

Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane.

Konishi M, Iwasa M, Araki J, Kobayashi Y, Katsuki A, Sumida Y, Nakagawa N, Kojima Y, Watanabe S, Adachi Y, Kaito M.

J Gastroenterol Hepatol. 2006 Dec;21(12):1821-5.

PMID:
17074020
13.

Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.

Sanyal AJ, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Stravitz RT, Mills AS.

Am J Gastroenterol. 2003 Sep;98(9):2064-71.

PMID:
14499789
14.

Human immunodeficiency virus is the major determinant of steatosis and hepatitis C virus of insulin resistance in virus-associated fatty liver disease.

Guaraldi G, Lonardo A, Ballestri S, Zona S, Stentarelli C, Orlando G, Carli F, Carulli L, Roverato A, Loria P.

Arch Med Res. 2011 Nov;42(8):690-7. doi: 10.1016/j.arcmed.2011.12.009. Epub 2012 Jan 4.

PMID:
22227046
15.

Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men.

Park SH, Kim BI, Yun JW, Kim JW, Park DI, Cho YK, Sung IK, Park CY, Sohn CI, Jeon WK, Kim H, Rhee EJ, Lee WY, Kim SW.

J Gastroenterol Hepatol. 2004 Jun;19(6):694-8.

PMID:
15151626
16.

Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes.

Narasimhan S, Gokulakrishnan K, Sampathkumar R, Farooq S, Ravikumar R, Mohan V, Balasubramanyam M.

Clin Biochem. 2010 Jul;43(10-11):815-21. doi: 10.1016/j.clinbiochem.2010.04.003. Epub 2010 Apr 14.

PMID:
20398645
17.

Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease.

Genc H, Dogru T, Kara M, Tapan S, Ercin CN, Acikel C, Karslioglu Y, Bagci S.

Ann Hepatol. 2013 Jul-Aug;12(4):548-55.

18.

Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload.

Lecube A, Hernández C, Simó R.

Diabetes Metab Res Rev. 2009 Jul;25(5):403-10. doi: 10.1002/dmrr.972. Review.

PMID:
19444865
19.

Association of pro-inflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver disease.

Kumar R, Prakash S, Chhabra S, Singla V, Madan K, Gupta SD, Panda SK, Khanal S, Acharya SK.

Indian J Med Res. 2012 Aug;136(2):229-36.

20.

Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.

Mager DR, Yap J, Rodriguez-Dimitrescu C, Mazurak V, Ball G, Gilmour S.

Nutr Clin Pract. 2013 Feb;28(1):101-11. doi: 10.1177/0884533612454884. Epub 2012 Oct 5.

PMID:
23042833

Supplemental Content

Support Center